Arai T, Hayashi E, Maeda S, Matsubara T, Fujii H, Shinohara K
Nat Commun. 2025; 16(1):1950.
PMID: 40082404
PMC: 11906622.
DOI: 10.1038/s41467-025-57167-0.
Park J, Lee J, Wang F, Ma H, Zhou Z, Lee Y
Exp Mol Med. 2025; 57(2):450-465.
PMID: 39939782
PMC: 11873038.
DOI: 10.1038/s12276-025-01408-1.
Yang H, Atak D, Yuan M, Li M, Altay O, Demirtas E
Cell Rep Med. 2025; 6(2):101935.
PMID: 39889710
PMC: 11866494.
DOI: 10.1016/j.xcrm.2025.101935.
Xiang L, Li X, Luo Y, Zhou B, Liu Y, Li Y
Life Metab. 2025; 1(3):242-257.
PMID: 39872077
PMC: 11749464.
DOI: 10.1093/lifemeta/loac034.
Alhermi A, Perks H, Nigi V, Altahoo N, Atkin S, Butler A
Biomolecules. 2025; 15(1).
PMID: 39858445
PMC: 11764088.
DOI: 10.3390/biom15010051.
Risk factors for metabolic syndrome in the premetabolic state assessed using hierarchical clustering study in a health screening group.
Park S, Kim Y, Oh B, Kang J
Sci Rep. 2024; 14(1):31169.
PMID: 39732771
PMC: 11682037.
DOI: 10.1038/s41598-024-82513-5.
A metabolic dysfunction-associated steatotic liver acinus biomimetic induces pancreatic islet dysfunction in a coupled microphysiology system.
Aleman J, K R, Wiegand C, Schurdak M, Vernetti L, Gavlock D
Commun Biol. 2024; 7(1):1317.
PMID: 39397070
PMC: 11471816.
DOI: 10.1038/s42003-024-07006-7.
Fetuin-B Interacts With Insulin Receptor-β and Promotes Insulin Resistance in Retina Cells.
Zhang W, Wang X, Tian S, Wang J, Zhou A
Invest Ophthalmol Vis Sci. 2024; 65(12):16.
PMID: 39382879
PMC: 11469143.
DOI: 10.1167/iovs.65.12.16.
Metabolic dysfunction-associated steatotic liver disease heterogeneity: Need of subtyping.
Habib S
World J Gastrointest Pathophysiol. 2024; 15(2):92791.
PMID: 38845820
PMC: 11151879.
DOI: 10.4291/wjgp.v15.i2.92791.
Delineation of renal protein profiles in aristolochic acid I-induced nephrotoxicity in mice by label-free quantitative proteomics.
Liu X, Wu S, Peng Y, Gao L, Huang X, Deng R
Front Pharmacol. 2024; 15:1341854.
PMID: 38783935
PMC: 11111959.
DOI: 10.3389/fphar.2024.1341854.
Hepatokine ITIH3 protects against hepatic steatosis by downregulating mitochondrial bioenergetics and lipogenesis.
Talari N, Mattam U, Kaminska D, Sotomayor-Rodriguez I, Rahman A, Peterfy M
iScience. 2024; 27(5):109709.
PMID: 38689636
PMC: 11059128.
DOI: 10.1016/j.isci.2024.109709.
Calorie Restriction Using High-Fat/Low-Carbohydrate Diet Suppresses Liver Fat Accumulation and Pancreatic Beta-Cell Dedifferentiation in Obese Diabetic Mice.
Lei X, Ishida E, Yoshino S, Matsumoto S, Horiguchi K, Yamada E
Nutrients. 2024; 16(7).
PMID: 38613031
PMC: 11013071.
DOI: 10.3390/nu16070995.
Systemic proteome adaptions to 7-day complete caloric restriction in humans.
Pietzner M, Uluvar B, Kolnes K, Jeppesen P, Frivold S, Skattebo O
Nat Metab. 2024; 6(4):764-777.
PMID: 38429390
PMC: 7617311.
DOI: 10.1038/s42255-024-01008-9.
Liver-derived extracellular vesicles improve whole-body glycaemic control via inter-organ communication.
Miotto P, Yang C, Keenan S, De Nardo W, Beddows C, Fidelito G
Nat Metab. 2024; 6(2):254-272.
PMID: 38263317
DOI: 10.1038/s42255-023-00971-z.
Organoid-guided precision hepatology for metabolic liver disease.
Osonoi S, Takebe T
J Hepatol. 2024; 80(5):805-821.
PMID: 38237864
PMC: 11828489.
DOI: 10.1016/j.jhep.2024.01.002.
Plasma proteome profiling reveals the therapeutic effects of the PPAR pan-agonist chiglitazar on insulin sensitivity, lipid metabolism, and inflammation in type 2 diabetes.
Wang X, Wang Y, Hou J, Liu H, Zeng R, Li X
Sci Rep. 2024; 14(1):638.
PMID: 38182717
PMC: 10770401.
DOI: 10.1038/s41598-024-51210-8.
Inferring secretory and metabolic pathway activity from omic data with secCellFie.
Masson H, Samoudi M, Robinson C, Kuo C, Weiss L, Shams Ud Doha K
Metab Eng. 2023; 81:273-285.
PMID: 38145748
PMC: 11177574.
DOI: 10.1016/j.ymben.2023.12.006.
The Interconnection between Hepatic Insulin Resistance and Metabolic Dysfunction-Associated Steatotic Liver Disease-The Transition from an Adipocentric to Liver-Centric Approach.
Veskovic M, Sutulovic N, Hrncic D, Stanojlovic O, Macut D, Mladenovic D
Curr Issues Mol Biol. 2023; 45(11):9084-9102.
PMID: 37998747
PMC: 10670061.
DOI: 10.3390/cimb45110570.
Circulating acyl-CoA-binding protein/diazepam-binding inhibitor in gestational diabetes mellitus.
Schurfeld R, Baratashvili E, Wurfel M, Bluher M, Stumvoll M, Tonjes A
Reprod Biol Endocrinol. 2023; 21(1):96.
PMID: 37872629
PMC: 10591366.
DOI: 10.1186/s12958-023-01152-z.
Inter-organ crosstalk during development and progression of type 2 diabetes mellitus.
Xourafa G, Korbmacher M, Roden M
Nat Rev Endocrinol. 2023; 20(1):27-49.
PMID: 37845351
DOI: 10.1038/s41574-023-00898-1.